By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Penwest Pharmaceutical 

2981 Route 22

Patterson  New York  12563-9970  U.S.A.
Phone: 914-878-3414 Fax:



Drug Discovery

Company News
Penwest Pharmaceutical (PPCO) Shareholders Approve Merger With Subsidiary of Endo Pharmaceuticals (ENDP) 11/5/2010 7:34:41 AM
Penwest Pharmaceutical (PPCO) Announces Intention to Terminate NASDAQ Listing and Registration 10/18/2010 7:06:56 AM
Penwest Pharmaceutical (PPCO) Sets Special Shareholders Meeting Date for Approval of Merger With Subsidiary of Endo Pharmaceuticals (ENDP) 10/1/2010 8:47:16 AM
Endo Pharmaceuticals (ENDP) Successfully Completes Tender Offer for Shares of Penwest Pharmaceutical (PPCO) 9/21/2010 8:25:55 AM
Endo Pharmaceuticals (ENDP) to Buy Penwest Pharmaceutical (PPCO) for About $168 Million and Submits NDA For New Formulation of Long-Acting Oxymorphone Designed to be Crush-Resistant 8/9/2010 3:18:34 PM
Penwest Pharmaceutical (PPCO) Q2 Revenues Up, but Job Cuts Likely 8/5/2010 7:19:29 AM
Penwest Pharmaceutical (PPCO) Reports Record Revenue and Earnings for Second Quarter of 2010 8/4/2010 10:08:46 AM
Penwest Pharmaceutical (PPCO)'s Board Approves Corporate Governance Changes and Selects New Chairman 8/2/2010 1:15:48 PM
Penwest Pharmaceutical (PPCO) to Present at Upcoming Conferences 7/29/2010 9:23:06 AM
Shareholders of Penwest Pharmaceutical (PPCO) Elect Tang Capital and Perceptive Nominees to the Board 6/22/2010 10:18:23 AM